Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease

Journal of Neuroscience Research

Volumn 55, Issue 2, 1999, Pages 218-229

  Beckstrøm, Henning ^a   Julsrud, Lars ^a   Haugeto, Øyvind ^a   Dewar, Deborah ^b   Graham, David I ^b   Lehre, Knut Petter ^a   Storm Mathisen, Jon ^a   Danbolt, Niels C ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Alzheimer's disease; Glial fibrillary acidic protein; Glutamate uptake; Immunoblotting; IP3 receptor; Reconstitution

Indexed keywords

ASPARTIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LIPOSOME;

AGED; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPSY; BRAIN LEVEL; CARBOXY TERMINAL SEQUENCE; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; GLUTAMIC ACID; GYRUS CINGULI; HUMANS; IMMUNOBLOTTING; MALE; MOLECULAR SEQUENCE DATA; POSTMORTEM CHANGES; RATS; RECEPTORS, NEUROTRANSMITTER; TEMPORAL LOBE;

EID: 0033556396     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.0.CO;2-L     Document Type: Article

References (70)

1. Adams C. 1997. Alzheimer's disease research: a game of connect the dots. Gerontology 43:8-19.
2. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG. 1994. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14:5559-5569.
3. Arriza JL, Eliasof S, Kavanaugh MP, Amara SG. 1997. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 94:4155-4160.
4. Butterfield DA. 1997. beta-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chemical ResToxicol 10:495-506.
5. Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J. 1990. Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Proc Natl Acad Sci USA 87:1352-1356.
6. Chaudhry FA, Lehre KP, Campagne MV, Ottersen OP, Danbolt NC, Storm-Mathisen J. 1995. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15: 711-720.
7. Choi DW, Hartley DM. 1993. Calcium and glutamate-induced cortical neuronal death. In: Waxman SG, editor. Molecular and cellular approaches to the treatment of neurological disease. Vol. 71. New York: Raven Press Ltd. p 23-34.
8. Cotman CW, Su JH. 1996. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 6:493-506.
9. Cotman CW, Tenner AJ, Cummings BJ. 1996. beta-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol Aging 17:723-731.
10. Cowburn R, Hardy J, Roberts P, Briggs R. 1988. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci Lett 86:109-113.
11. 3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neurosci Lett 79:213-7.
12. Cummings BJ, Pike CJ, Shankle R, Cotman CW. 1996. beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging 17:921-933.
13. Danbolt NC. 1994. The high affinity uptake system for excitatory amino acids in the brain. Prog Neurobiol 44:377-396.
14. Danbolt NC, Storm-Mathisen J. 1986. Na + -dependent "binding" of D-aspartate in brain membranes is largely due to uptake into membrane bounded saccules. J Neurochem 47:819-24.
15. Danbolt NC, Pines G, Kanner BI. 1990. Purification and reconstitution of the sodium-and potassium-coupled glutamate transport glycoprotein from rat brain. Biochemistry 29:6734-40.
16. de la Torre JC. 1997. Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 43:26-43.
17. Dewar D, Chalmers DT, Graham DI, McCulloch J. 1991. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease - an autoradiographic study of the hippocampus. Brain Res 553:58-64.
18. Eikelenboom P, Zhan SS, Vangool WA, Allsop D. 1994. Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15:447-450.
19. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG. 1995. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375:599-603.
20. Finch CE, Cohen DM. 1997. Aging, metabolism, and Alzheimer disease: Review and hypotheses. Exp Neurol 143:82-102.
21. Fonnum F. 1984. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42:1-11.
22. Forloni G, Tagliavini F, Bugiani O, Salmona M. 1996. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides. Prog Neurobiol 49:287-315.
23. Gegelashvili G, Danbolt NC, Schousboe A. 1997. Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J Neurochem 69:2612-2615.
24. Ginsberg SD, Martin LJ, Rothstein JD. 1995. Regional deafferentation down-regulates subtypes of glutamate transporter proteins. J Neurochem 65:2800-2803.
25. Greenamyre JT, Penney JB, Young AB, D'Amato CJ, Hicks SP, Shoulson I. 1985. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 277:1496-1499.
26. Hardy J, Cowburn R, Barton A, Reynolds G, Lofdahl E, O'Carroll AM, Wester P, Winblad B. 1987. Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 73:77-80.
27. Harris ME, Carney JM, Cole PS, Hensley K, Howard BJ, Martin L, Bummer P, Wang YN, Pedigo NW, Butterfield DA. 1995. Beta-amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport 6:1875-1879.
28. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67:277-286.
29. Haug LS, Østvold AC, Cowburn RF, Garlind A, Winblad B, Bogdanovich N, Walaas SI. 1996. Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration 5:169-176.
30. Haugeto Ø, Ullensvang K, Levy LM, Chaudhry FA, Honoré T, Nielsen M, Lehre KP, Danbolt NC. 1996. Brain glutamate transporter proteins form homomultimers. J Biol Chem 271:27715-27722.
31. Kawakami H, Tanaka K, Nakayama T, Inoue K, Nakamura S. 1994. Cloning and expression of a human glutamate transporter. Biochem Biophys Res Commun 199:171-176.
32. Kanai Y, Hediger MA. 1992. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360: 467-471.
33. Keller JN, Mark RJ, Bruce AJ, Blanc E, Rothstein JD, Uchida K, Waeg G, Mattson MP. 1997a. 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80:685-696.
34. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, Mattson MP. 1997b. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J Neurochem 69:273-284.
35. Khachaturian ZS. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
36. Knecht K, Michalak A, Rose C, Rothstein JD, Butterworth RF. 1997. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 229:201-203.
37. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
38. Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. 1995. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15:1835-1853.
39. Lendon CL, Ashall F, Goate AM. 1997. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277:825-831.
40. +]coupled L-glutamate transporter purified from rat brain confirms glial cell localization. FEBS Lett 317:79-84.
41. Levy LM, Lehre KP, Walaas SI, Storm-Mathisen J, Danbolt NC. 1995. Down-regulation of glial glutamate transporters after glutamatergic denervation in the rat brain. Eur J Neurosci 7:2036-2041.
42. Li S, Mallory M, Alford M, Tanaka S, Masliah E. 1997. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56:901-911.
43. Lin CLG, Bristol LA, Jin L, Dykeshoberg M, Crawford T, Clawson L Rothstein JD. 1998. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2 a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20:589-602.
44. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
45. Manfras BJ, Rudert WA, Trucco M, Boehm BO. 1994. Cloning and characterization of a glutamate transporter cDNA from human brain and pancreas. Biochim Biophys Acta 1195:185-188.
46. Masliah E, Alford M, Deteresa R, Mallory M, Hansen L. 1996a. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40:759-766.
47. Masliah E, Mallory M, Veinbergs I, Miller A, Samuel W. 1996b. Alterations in apolipoprotein E expression during aging and neurodegeneration. Prog Neurobiol 50:493-503.
48. Mattson MP. 1997. Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci 20:373-375.
49. McGeer EG, Singh EA, McGeer PL. 1987. Sodium-dependent glutamate binding in senile dementia. Neurobiol Aging 8:219-223.
50. Norenberg MD, Huo ZF, Neary JT, Roigcantesano A. 1997. The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: relation to energy metabolism and glutamatergic neurotransmission. Glia 21:124-133.
51. Obrenovitch TP, Urenjak J. 1997. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 51:39-87.
52. Olney JW. 1989. Excitatory amino acids and neuropsychiatric disorders. Biol Psychiat 26:505-525.
53. Pines G, Danbolt NC, Bjoørås M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg EK, Kanner BI. 1992. Cloning and expression of a rat brain L-glutamate transporter. Nature 360:464-467.
54. Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM. 1988. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem 50:790-802.
55. Rothstein JD, Martin LJ, Kuncl RW. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New Eng J Med 326:1464-1468.
56. Rothstein JD, Martin L, Levey AI, Dykeshoberg M, Jin L, Wu D, Nash N, Kuncl RW. 1994. Localization of neuronal and glial glutamate transporters. Neuron 13:713-725.
57. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. 1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
58. Scheuer K, Maras A, Gattaz WF, Cairns N, Forstl H, Muller WE. 1996. Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. Dementia 7:210-214.
59. Scott HL, Tannenberg AEG, Dodd PR. 1995. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem. 64:2193-2202.
60. Shashidharan P, Plaitakis A. 1993. Cloning and characterization of a glutamate transporter cDNA from human cerebellum. Biochim Biophys Acta 1216:161-164.
61. Shashidharan P, Wittenberg I, Plaitakis A. 1994. Molecular cloning of human brain glutamate/aspartate transporter II. Biochim Biophys Acta 1191:393-396.
62. 3H]TCP binding sites in Alzheimer's disease brains. Brain Res 462:76-82.
63. Smith MA. 1998. Alzheimer disease. Int Rev Neurobiol 42:1-54.
64. Smith MA, Sayre LM, Monnier VM, Perry G. 1995. Radical AGEing in Alzheimer's disease. Trends Neurosci 18:172-176.
65. +-dependent glutamate/ aspartate transporter from rat brain. Proc Natl Acad Sci USA 89:10955-10959.
66. Tanaka K. 1993. Expression cloning of a rat glutamate transporter. Neurosci Res 16:149-153.
67. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
68. Trotti D, Volterra A, Lehre KP, Rossi D, Gjesdal O, Racagni G, Danbolt NC. 1995. Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane. J Biol Chem 270:9890-9895.
69. van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RDJ, Salehi A, Martens GJM, Grosveld FG, Peter J, Burbach H, Hol EM. 1998. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279:242-247.
70. Ying WH. 1997. Deleterious network: a testable pathogenetic concept of Alzheimer's disease. Gerontology 43:242-253.